Skip to main content

Prellis Biologics advances 3D printing of human tissue with capillaries

Prellis Biologics, a San Francisco-based 3D tissue printing company, announced that it has reached record speed and resolution in the quest to print human tissue with viable capillaries. Once perfected, this technique will bring the goal of printing human replacement organs closer to reality.

‘A major goal in tissue engineering is to create viable human organs, but nobody could print tissue with the speed and resolution needed to form viable capillaries,’ said Melanie Matheu, PhD, CEO and co-founder of Prellis Biologics. ‘At Prellis, we’ve now developed that technology, paving the way for important medical advances and, ultimately, functional organ replacements.’

Prellis’ holographic 3D printing technology can create the complex microvascular and scaffolding that allows human tissue to survive. Printing speed is crucial, since cells can only survive for a limited amount of time without a blood supply. And tissue that is densely packed with cells will die in less than 30 minutes unless oxygen and nutrients can be supplied immediately, through capillaries.

Fine printing resolution is as vital as speed, since capillaries are microscopic in size —about 5 to 10 microns in diameter (in comparison, a human hair is 75 to 100 microns). Prellis’ technology can print with resolutions as small as 0.5 microns.

Until now, it would take weeks or more to print just a centimetre cube of human tissue with microvasculature. Prellis’ technology can print high-resolution tissue structures up to 1000 times faster, with the vasculature in place. ‘The speed we can achieve is limited only by the configuration of the optical system,’ comments Dr Matheu. ‘We are now exploring custom optical system development, which will dramatically increase our capabilities. Our ultimate goal is to print the entire vascular system of a kidney in 12 hours or less.’

‘Vasculature is a key feature of complex tissues and is essential for engineering tissue with therapeutic value,’ observed Todd Huffman, CEO of 3Scan, an advanced digital tissue imaging and data analysis company. ‘Prellis’ advancement represents a key milestone in the quest to engineer organs.’

Jordan Miller, PhD, Assistant Professor of Bioengineering at Rice University and an expert in 3D-printed implantable biomaterial structures, affirmed the importance of Prellis’ work. ‘Microvasculature is the fundamental architectural unit that supports advanced multicellular life and it therefore represents a crucial target for bottom-up human tissue engineering and regenerative medicine.’

An estimated 330 people in the United States die each day due to organ failure. Replacement organs and tissues will both lower costs and free patients from dialysis, oxygen tanks, daily insulin injections, and other life-altering interventions.

For more in-depth information about Prellis and the state of the human tissue engineering field, see Prellis’ white paper here.


Media Partners